Sale!
Epitope Prediction and Neoantigen Vaccine Design Course
Original price was: USD $120.00.USD $59.00Current price is: USD $59.00.
Vaccine design has become more computational, but not necessarily simpler. The difficulty is no longer just finding an antigen. It is deciding which epitopes are likely to bind, trigger, persist, and remain useful across real biological variation.
This course is a three-day training program in epitope prediction, neoantigen biology, and AI-assisted vaccine design. It covers immunoinformatics foundations, B-cell and T-cell epitope analysis, machine learning tools for antigen ranking, and in silico validation steps used to build candidate multi-epitope vaccines.
About the Course
This course focuses on the logic and workflow behind epitope prediction and neoantigen-informed vaccine design. It starts with the biological foundations of immune recognition, then moves into computational methods used to identify promising epitopes, rank them with AI-assisted tools, and assemble them into candidate vaccine constructs for in silico evaluation.
Most course pages in this area stay vague. They mention immunoinformatics and list a few tools, but leave the missing piece: how prediction, ranking, and validation fit together. Serious learners want to know where the decision points are, what each tool actually contributes, and how a predicted epitope becomes part of a defensible vaccine-design workflow.
This program addresses that gap directly. Day 1 establishes the biology; Day 2 shifts into machine learning and deep learning methods for MHC binding prediction; and Day 3 moves into multi-epitope vaccine design, including adjuvants, allergenicity screening, toxicity assessment, and structural validation.
Why This Topic Matters
Epitope prediction now sits at the center of vaccine development, cancer immunotherapy, and personalized antigen design. Experimental screening is expensive and slow; immunoinformatics helps narrow the search space, allowing researchers to estimate MHC binding, antigenicity, and population coverage before reaching the lab.
However, prediction is not proof. A serious course must teach both the utility and the limits of the tools. MHC binding scores are informative, but they do not automatically translate into clinical usefulness. The same is true for antigenicity models and structural predictions.
For researchers, this knowledge supports stronger computational pipelines. For biotech professionals, it sharpens the ability to interpret prediction outputs rather than just generate them.
What Participants Will Learn
• Distinguish between B-cell and T-cell epitope analytics
• Explain the role of neoantigens in cancer immunotherapy
• Use core tools like IEDB, NetMHC, and VaxiJen
• Interpret MHC binding and immunogenicity outputs
• Apply machine learning and deep learning to predictions
• Compare NetMHCpan, DeepImmuno, and DeepVacPred
• Design multi-epitope constructs with linkers and adjuvants
• Assess population coverage, allergenicity, and toxicity
• Use AllerTOP, ToxinPred, and PEP-FOLD for refinement
• Recognize common weaknesses in design pipelines
Course Structure / Table of Contents
Module 1 — Fundamentals of Vaccinology and Immunoinformatics
- Core concepts in immune recognition and vaccine design
- Introduction to computational vaccinology and immunoinformatics
- Why epitope-focused workflows matter in modern antigen discovery
- How in silico screening supports experimental prioritization
Module 2 — Epitopes, Neoantigens, and Biological Context
- B-cell versus T-cell epitopes: definitions and differences
- Antigen processing and MHC presentation basics
- Neoantigens in cancer biology and personalized vaccines
- Biological factors that influence immunogenicity prediction relevance
Module 3 — Foundational Epitope Prediction Tools
- Introduction to IEDB, NetMHC, and VaxiJen
- Basic epitope prediction workflow design
- Demo: using IEDB for introductory prediction tasks
- Reading outputs without overinterpreting binding scores
Module 4 — AI and Machine Learning in Epitope Prediction
- Machine learning approaches to epitope prediction
- Deep learning for antigenicity and MHC binding estimation
- How model-based ranking differs from rule-based filtering
- Practical considerations in training data quality and model bias
Module 5 — Advanced Tools for AI-Based Prediction
- NetMHCpan for broader allele-aware binding prediction
- DeepImmuno for immunogenicity-focused analysis
- DeepVacPred for AI-supported vaccine candidate selection
- Comparative use of multiple tools within a single workflow
Module 6 — Case Study and Hands-on Epitope Ranking
- Case study: cancer-specific neoantigen prediction
- Designing an AI-based workflow for epitope ranking
- Interpreting competing outputs across different platforms
- Prioritizing candidates for downstream laboratory validation
Module 7 — Multi-epitope Vaccine Design
- Constructing a multi-epitope vaccine sequence
- Role of linkers in epitope arrangement and processing
- Adjuvant selection logic in in silico design
- Balancing immunogenic promise with construct feasibility
Module 8 — In Silico Validation and Candidate Refinement
- Population coverage analysis across diverse HLA alleles
- Allergenicity prediction using AllerTOP and toxicity via ToxinPred
- Structural modeling considerations with PEP-FOLD
- Final demo: designing a candidate vaccine using the AI pipeline
| Course Dimension | Theory-Oriented Coverage | Hands-On Coverage |
|---|---|---|
| Epitope Biology | B-cell vs T-cell logic, MHC presentation | Interactive pathogen data retrieval |
| AI Prediction | ML models, binding estimation theory | Ranking epitopes via DeepImmuno/NetMHCpan |
| Vaccine Design | Linkers, adjuvants, construct logic | Assembling a multi-epitope construct |
| In Silico Validation | Toxicity, allergenicity, structural rules | Screening candidates via ToxinPred/AllerTOP |
Tools, Techniques, or Platforms Covered
IEDB
NetMHCpan
VaxiJen
DeepImmuno
ToxinPred
PEP-FOLD
AllerTOP
NetMHCpan
VaxiJen
DeepImmuno
ToxinPred
PEP-FOLD
AllerTOP
Real-World Applications
Cancer Immunotherapy: Epitope prediction supports neoantigen discovery for personalized therapeutic vaccine design.
Infectious Disease: Helps narrow potential targets for infectious pathogens before moving into expensive lab validation.
Biotech R&D: Improves the structure of early-stage antigen selection and improves the speed of candidate screening.
Who Should Attend
- PhD scholars working on cancer immunotherapy or vaccine design
- Postgraduate students in bioinformatics, immunology, or biotechnology
- Academic researchers building immunoinformatics workflows
- Faculty supervising computational vaccinology or peptide-design projects
- Biotech and pharma professionals involved in antigen screening
Prerequisites or Recommended Background
Basic molecular biology or biotechnology knowledge. Familiarity with antigens, peptides, and immune response concepts. No prior coding experience is necessary, but introductory exposure to bioinformatics analysis is helpful.
Why This Course Stands Out
This course is organized around actual workflow decisions rather than abstract tool lists. It treats AI as part of a decision pipeline, balancing immunogenic promise with feasibility. It carries the learner through the full cycle: from prediction and ranking to construct assembly and validation.
Frequently Asked Questions
What is this course about?
It is a 3-day course on epitope prediction and AI-assisted vaccine design, covering neoantigen biology, ranking methods, and in silico validation.
Do I need prior coding experience?
Not necessarily. The course is primarily built around understanding workflows, prediction tools, and interpretation rather than advanced programming.
Will the course include hands-on work?
Yes. It includes demonstrations and practical sessions using tools such as IEDB and AI-based ranking platforms.
How is this useful in research or industry?
It helps technical teams structure early-stage antigen screening and improve candidate prioritization with more rigor.
Is this focused on cancer only?
No. Cancer-specific neoantigens are included, but the logic applies to broader infectious disease and immunoinformatics applications.
Is this course beginner-friendly?
It is accessible to learners with a foundation in life sciences. It is designed for serious beginners with some context.
Related products
-
AI Integration in Healthcare Management Course
USD $59.00 USD $249.00Price range: USD $59.00 through USD $249.00 Select options This product has multiple variants. The options may be chosen on the product page -
Nanotechnology in Agricultural Biotechnology Course
USD $59.00 USD $249.00Price range: USD $59.00 through USD $249.00 Select options This product has multiple variants. The options may be chosen on the product page -
Microarray Based Gene Expression Analysis using R Programming Course
USD $59.00 USD $249.00Price range: USD $59.00 through USD $249.00 Select options This product has multiple variants. The options may be chosen on the product page -
Single Nucleotide Polymorphism (SNP) Detection and Analysis using NGS Course
USD $59.00 USD $249.00Price range: USD $59.00 through USD $249.00 Select options This product has multiple variants. The options may be chosen on the product page -
Next-Generation Sequencing Data Analysis using Galaxy Platform Course
USD $59.00 USD $249.00Price range: USD $59.00 through USD $249.00 Select options This product has multiple variants. The options may be chosen on the product page
What You’ll Gain
- Full access to e-LMS
- Publication opportunity
- Self-assessment & final exam
- e-Certificate
Reviews
There are no reviews yet.